The POU transcription factor human specifically promotes the proliferation of keratinocytes and enhances their differentiation. We examined the effects of hSkn-1a on cervical cancer cell lines of epithelial origin, in which the differentiation program is interrupted. From HeLa/Tet-On, a clone that can be induced to make hSkn-1a by doxycycline (HeLa/hSkn-1a) was prepared and characterized. Shortly after the induction, the cells expressed cytokeratin 10 (K10), a major marker protein in differentiating keratinocytes. While maintained for several days in the presence of doxycycline, the HeLa/hSkn1a cells showed a slightly prolonged time of population doubling, the occasional appearance of flat cells with lowered DNA synthesis, and a low level of apoptotic DNA fragmentation. In SiHa and HeLa S3 cultures, K10 mRNA and apoptotic DNA fragmentation were detected at 48 h after infection with an adenoviral vector capable of expressing hSkn-1a. A colony inhibition assay showed that the growth of HeLa S3, SiHa, CaSki, and C-33A cells was repressed, as seen from the decreased number and average size of the drug-resistant colonies at 2 or 3 weeks after transfection with a plasmid that can express hSkn-1a and neomycin resistance gene. These results suggest that the expression of hSkn-1a represses the growth of the cervical cancer cells through the partial resumption of the differentiation pathway followed by slow suppression of cell replication and apoptosis.
Introduction
Histopathological studies show that the interruption of differentiation pathways is a common phenotypic feature of cancer cells. It is generally believed that differentiation and malignancy are inversely correlated, but the defects in differentiation are not obligatory or causal events in carcinogenesis (Fusenig et al., 1995) . Many types of cancer cells retain the potential to differentiate in response to external differentiation stimuli, such as retinoic acid (Altucci and Gronemeyer, 2002) . The remaining differentiation capacity of cancer cells provides a basis for a new therapeutic strategy, the differentiation therapy. For the development of this strategy, more studies are needed about the differentiation control of cells and differentiation capacity of cancer cells.
Cell differentiation is regulated by transcription factors. Mammalian proteins Pit-1 and Oct-2 and Caenorhabditis elegans protein unc-86 (Finney and Ruvkun, 1990) induce terminal differentiation of pituitary cells, Blymphocytes, and neuronal cells, respectively. These factors containing common DNA-binding domain, named POU domain, are grouped as the POU domain family (Herr et al., 1988) . Rat Skn-1a and human , which are members of the POU domain family, are primarily expressed in differentiating suprabasal keratinocytes, but not in proliferating basal cells (Andersen et al., 1993) . They activate genes encoding cytokeratin 10 (K10) (Andersen et al., 1993) , a major marker protein for differentiating keratinocytes, and small proline-rich protein 2A (Fischer et al., 1996) , and downregulate genes encoding involucrin (Welter et al., 1996) and profilaggrin (Jang et al., 2000) . A recent study shows that hSkn-1a contributes to epidermal stratification by promoting keratinocyte proliferation and by enhancing the subsequent keratinocyte differentiation (Hildesheim et al., 2001) . Thus, hSkn-1a is likely to trigger and regulate the differentiation of epithelial cells.
In this study, we designed the experiments to describe how the cancer cells derived from keratinocytes respond to the expression of hSkn-1a, which triggers the process of normal keratinocyte differentiation leading to cell death. We prepared and characterized a HeLa line that can induce expression of hSkn-1a placed under the control of a tetracycline-inducible promoter (HeLa/ hSkn-1a). We found that in the HeLa cells, the hSkn-1a expression upregulates K10 (a typical marker gene) expression, and, subsequently, repress cell growth and induce DNA fragmentation in some of the cells. These changes seem to be part of the differentiation, because some upregulated genes are common to the induced HeLa/hSkn-1a and the primary keratinocytes that have started differentiation, as reported recently (Enomoto et al., 2003) . Thus, this study shows that HeLa cells retain part of the potential for differentiation. To extend these findings to other cervical cancer cell lines, we used a transient expression system and a colony inhibition assay. For comparison we also examined two cell lines from hepatocellular carcinoma, an immortalized keratinocyte cell line, and a transformed human kidney cell line.
Results
Doxycyline-induced expression of hSkn-1a in HeLa/ hSkn-1a, a HeLa clone containing the inducible gene To study how HeLa, a representative cell line from cervical carcinoma, responds to the expression of hSkn1a, we prepared HeLa/hSkn-1a, a cell line that expresses hSkn-1a in the presence of doxycycline. In the lysate of HeLa/hSkn-1a cultured without doxycycline, hSkn-1a was not detected by immunoblotting using anti-Skn-1a antibody ( Figure 1a ). The addition of doxycycline of 0.1 mg/ml to the medium induced a detectable level of hSkn-1a and of 2 mg/ml the maximum level ( Figure 1a) . Therefore, doxycycline of 2 mg/ml was used for the induction of hSkn-1a in the following experiments. The parental HeLa/Tet-On cultured in the medium with doxycycline of 2 mg/ml for 2 days did not produce hSkn1a, indicating doxycycline itself did not induce hSkn-1a (Figure 1d ). After the addition of doxycycline, hSkn-1a in HeLa/hSkn-1a became detectable at 15 min and then its level raised, indicating the induction is very rapid (Figure 1b) .
The immunofluorescence staining of the HeLa/hSkn1a culture incubated with doxycycline for 4 days showed strong nuclear immunofluorescence in accordance with nuclear localization of hSkn-1a (Figure 1c) . Although all the cells in the culture were positive for hSkn-1a, the levels of hSkn-1a slightly varied from cell to cell. When the HeLa/hSkn-1a culture was maintained in the growth medium containing doxycycline, the number of cells with strong immunofluorescence reached maximum at 2 days after the induction and then became fewer gradually.
In parallel to the immunofluorescence data, immunoblotting showed that the amount of hSkn-1a in cellular extracts, which was adjusted to contain a fixed amount of cellular proteins, reached maximum at 2 days after the induction (Figure 1d ). The level of hSkn-1a was maintained for the following 3-5 days and then gradually lowered. Based on the above findings, we concluded that HeLa/hSkn-1a was appropriate to analyse cellular responses to hSkn-1a within 6 to 7 days after the induction.
Changes of HeLa/hSkn-1a cells resulting from the induced expression of hSkn-1a K10, one of the major marker proteins expressed in differentiating keratinocytes, was detectable by immunochemical staining in almost all the HeLa/hSkn-1a cells cultured in the presence of doxycycline for 3 days (Figure 2a ). The level of K10 in each cell varied as the level of hSkn-1a did (Figure 1d ). K10 was not detected in extract from the parental HeLa/Tet-On cultured with doxycycline of 2 mg/ml for 2 days (Figure 2b) . Changes of the total amount of K10 in the culture after the induction of hSkn-1a were shown by immunoblotting with anti-K10 antibody (Figure 2b ). K10 was detectable at 1 day after the induction and reached the highest level at 2 days. Then the level of K10 gradually lowered and Figure 1d . The expression of involucrin and filaggrin, the other marker proteins in the differentiating keratinocytes, were not detectable. Thus, the expression of hSkn-1a was followed by the expression of K10, indicating that HeLa/hSkn-1a maintained the capability of resuming a differentiation pathway leading to K10 expression.
The induction of hSkn-1a did not immediately cause any morphological changes of cells in the HeLa/hSkn-1a culture. However, at 3 days after the induction, flat and enlarged cells emerged ( Figure 3a) . Some of the flat cells appeared not to divide but to become larger at 7 days. The majority of flat cells disappeared when doxycycline was removed from the medium and incubated for further 3 days, indicating that the morphological changes depended on hSkn-1a and were reversible at this time point.
The incorporation of BrdU into nuclei, which is evidence of active DNA synthesis, was clearly decreased in some of the cells including the flat cells at 3 and 6 days after the induction (Figure 3b ). The level of BrdU varied from almost zero to close to the maximum among the cells in the culture, suggesting that the shut down of DNA synthesis did not occur uniformly at a time. When doxycycline was removed from the medium at 3 days and incubated for further 3 days, the incorporation of BrdU recovered, indicating that the lowered DNA synthesis also depended on hSkn-1a and were reversible at this time point.
Some of the cells, which were morphologically similar to those cultured without doxycycline, grew in the medium containing doxycycline. A small number of the flat cells were always present in the culture, suggesting that they were generated occasionally from some of the dividing cells. The number of cells in the culture dish was counted everyday with appropriate passages. The periods required for population doubling of HeLa/ hSkn-1a cultured in the growth medium for 6 days with or without doxycycline (2 mg/ml) were 17.8 h and 19.9 h, respectively.
The apoptotic fragmentation of chromosomal DNA was shown in total DNA extracted from HeLa/hSkn-1a culture at 3 days after the induction and it became more prominent at 6 days ( Figure 4 ). The level of the fragmented DNA in the culture incubated with doxycycline for 3 days and then incubated without doxycycline for 3 days was similar to the level of culture incubated Incorporation of BrdU by HeLa/hSkn-1a cultured under the presence of doxycycline HeLa/hSkn-1a was cultured without, with doxycycline for 3 or 6 days, or with 3 days followed by without for 3 days. Then, cells were cultured in the medium containing 10 mM BrdU for 15 min at 371C. The incorporated BrdU were visualized by immunochemically Growth repression of cervical cancer cell lines by hSkn-1a Y Enomoto et al with doxycycline for 3 days, suggesting strongly that apoptotic DNA fragmentation was associated with the expression of hSkn-1a.
The response of the HeLa clone to hSkn-1a was the apparent initiation of differentiation, as indicated by the production of K10, followed by some morphological change, the slow suppression of cell growth, and apoptosis. The changes that occur after the induction of K10 expression would be slow and unsynchronized, probably causing the apparent discrepancy between the K10 expression and morphological or biochemical alterations. Since none of these changes were induced by doxycycline in parental HeLa/Tet-On cells, we concluded that the changes were specific to the expression of hSkn-1a. To know whether these findings can be extended to the parental HeLa line and other cervical cancer cell lines, we used a transient expression system using adenovirus and a colony inhibition assay in the following sections.
Responses of HeLa S3 and SiHa to transiently expressed hSkn-1a
HeLa S3 and SiHa, another cervical cancer cell line, were examined for the expression of K10 mRNA and apoptotic DNA fragmentation after infection with a newly generated recombinant adenovirus expressing hSkn-1a (Ad/hSkn-1a). For comparison, Alexander and HepG2, cell lines derived from liver cancer, were similarly infected with Ad/hSkn-1a. These cells were selected because susceptibility of these cells to infection with the recombinant adenovirus was relatively high (data not presented). The steady-state hSkn-1a was not detectable in extracts from these cells by immunoblotting with anti-Skn-1a antibody (data not presented).
The infectivity of Ad/hSkn-1a was measured with HEK293 cells that support the propagation of the defective recombinant adenoviruses. For the cells, in which the recombinant adenovirus cannot propagate, it was necessary to inoculate the virus at a higher MOI. SiHa was infected at an MOI of 10 and the other cells at 100. The recombinant adenovirus expressing lacZ (Ad/ lacZ) was similarly inoculated to the cells. All the cells in the culture inoculated with Ad/hSkn-1a or Ad/lacZ at an indicated MOI were positive for hSkn-1a or lacZ, respectively, and just after the inoculation of the viruses (before the accumulation of the transgene product), these cells did not show any morphological abnormalities presumably resulting from the nonspecific cell toxicity of the inocula (data not presented).
After the infection with Ad/hSkn-1a, K10 mRNA was readily detectable in the HeLa S3, SiHa, and HepG2 cultures, but not induced in the Alexander culture. Total RNA was extracted from the cells at 2 days after the infection and level of K10 mRNA was measured by realtime RT-PCR (Figure 5a ). Levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA were similar in the cells infected with either Ad/hSkn-1a or Ad/lacZ (Figure 5b ), indicating that basic cellular metabolism was not affected by the infection with the recombinant adenovirus.
At 2 days after the infection with Ad/hSkn-1a, the cells positive for apoptotic DNA fragmentation were present in HeLa S3, SiHa, Alexander, and HepG2 cultures stained by TdT-mediated dUTP nick end labeling (TUNEL), which is a method to label the 3 0 -end of intracellular fragmented DNA for cytological detection (Figure 6 ). Apoptosis was the most prominent in Alexander among these cell lines. The apoptotic Figure 4 Apoptotic DNA fragmentation in HeLa/hSkn-1a after the induction of hSkn-1a. HeLa/hSkn-1a was cultured without or with doxycycline for 3 or 6 days, or with 3 days followed by without for 3 days. Apoptotic DNA fragments in total DNA extracted from the cells were amplified by LM-PCR Ladder Assay Kit (BD Biosciences Clontech), electrophoresed in a 1.2% agarose gel, and stained with ethidium bromide Figure 5 K10 and GAPDH mRNA in the cells infected with Ad/ hSkn-1a or Ad/lacZ. HeLa S3, SiHa, Alexander, and HepG2 were infected with the recombinant adenoviruses at an MOI of 10 for SiHa and 100 for other cells. After 2 days, total RNA was extracted and levels of K10 mRNA (a) and GAPDH mRNA (b) were quantified by real-time PCR using QuantiTect SYBR Green PCR Kit (QIAGEN GmbH) by ABI PRISM 7700 Sequence Detector (Applied Biosystems). Specificity of the reaction was verified by dissociation curve analysis and agarose-gel electrophoresis of PCR products Growth repression of cervical cancer cell lines by hSkn-1a Y Enomoto et al fragmented DNA was also present in total DNA extracted from the cells infected with Ad/hSkn-1a (data not presented).
Colony inhibition assay for cervical cancer cell lines transfected with a plasmid expressing hSkn-1a
The effects of hSkn-1a on the growth of the cervical cancer cell lines, HeLa S3, SiHa, CaSki, and C-33A, were evaluated by colony formation of cells transfected with pCMV-hSkn-1a/IRESneo (a plasmid expressing both hSkn-1a and neomycin resistance gene) or pCMVDsRed/IRESneo (a plasmid expressing DsRed1 and neomycin resistance gene). For comparison, HaCaT (immortalized human keratinocytes), Alexander, HEK293 (transformed human fibroblast), and COS-1 (transformed monkey epithelial cell) were included. Similar to the other cell lines, the steady-state hSkn-1a was not detectable in extracts from HaCaT and COS-1 cells by immunoblotting. Owing to the extremely low transfection efficiency, HepG2 was not included in the experiment. The expression of hSkn-1a or DsRed in the cells transfected with pCMV-hSkn-1a/IRESneo or pCMV-DsRed/IRESneo was confirmed by immunoblotting or fluorescence microscopy, respectively (data not presented). Table 1 summarizes the numbers of G418-resistant colonies of the cell lines and Figure 7 shows representative cultures with the drug-resistant colonies. All the cell lines derived from cervical cancers, HeLa S3, SiHa, CaSki, and C-33A, were found to be sensitive to colony inhibition by pCMV-hSkn-1a/IRESneo. The drug-resistant colonies formed after transfection with pCMVhSkn-1a/IRESneo were much fewer and sometimes smaller than those formed after transfection with pCMV-DsRed/IRESneo. For example, diameters of great majority of HeLa S3 colonies with pCMV-hSkn1a/IRESneo were less than 1 mm, although those with pCMV-DsRed/IRESneo were in the range from 1 to 3 mm. Besides the cervical cancer lines, HaCaT, an immortalized keratinocyte line, was found to be sensitive to the colony inhibition.
Whereas HEK293, an adenovirus E1A-transformed kidney cell line, was insensitive, Alexander, a hepatocellular carcinoma cell line, and COS-1, an SV40-transformed monkey kidney cell line, were sensitive to Figure 6 Apoptotic DNA fragmentation in the cells infected with Ad/hSkn-1a. HeLa S3, SiHa, Alexander, and HepG2 were infected with Ad/hSkn-1a or Ad/lacZ at the MOI indicated in figures. After 2 days, the cells containing fragmented DNA were detectable by staining the 3 0 -ends of DNA by TUNEL method in the culture infected with Ad/hSkn-1a Cells were transfected with pCMV-hSkn-1a/IRESneo, a plasmid encoding hSkn-1a and neomycine resistance gene, or pCMV-DsRed/ IRESneo, a plasmid encoding DsRed and neomycine resistance gene. Colonies formed with G418-resistant cells were scored. Colony counts per 1 mg plasmid in two or three independent experiments were presented with ratios of the counts obtained by pCMV/IRESneo to those obtained by pCMV-DsRed/IRESneo
Growth repression of cervical cancer cell lines by hSkn-1a Y Enomoto et al the expression of hSkn-1a in the colony inhibition assay. The results suggest that the keratinocyte origin may not be an absolute requirement for the sensitivity to hSkn-1a.
Discussion
We were interested in the effect of hSkn-1a on cervical cancer cell lines, because hSkn-1a is a keratinocytespecific transcription factor regulating differentiation, and because cervical cancer cells, whose differentiation capability is thought to be interrupted, are presumably of keratinocyte origin. The expression of hSkn-1a was not detectable in cervical cancer cells tested, being consistent with the previous observation that the level of hSkn-1a decreased with the progression of CIN from grades I-III (Hietala et al., 1997).
We prepared a HeLa clone that contains an inducible hSkn-1a gene (HeLa/hSkn-1a) and characterized the cells after the induction. HeLa/hSkn-1a expressed hSkn1a in response to doxycycline added to the culture medium. The induction of hSkn-1a in HeLa/hSkn-1a resulted in the expression of K10 in almost all the cells in a culture (Figure 2a) , indicating that hSkn-1a allowed the cells to resume the differentiation pathway leading to K10 expression. In addition, 3-6 days later, some flat cells with lowered DNA synthesis appeared in the culture (Figure 3) , and fragmented DNA was detected (Figure 4) . Most of the cells expressing hSkn-1a grew slowly with occasional production of the flat cells. DNA synthesis of these cells was reduced (Figure 3b) . Thus, the slow growth of the cells and the occasional apoptosis strongly suggest that hSkn-1a triggers the terminal differentiation pathway leading to the growth arrest. This apparent slow process may have mimicked only partly, but reflect what occurs in nature in keratinocyte differentiation composed of multisteps starting from transient active cell growth to the final cell death. The observations with HeLa/hSkn-1a were extended to other cervical cancer cell lines. The results suggest that in cervical cancer cells hSkn-1a can trigger the initial step of differentiation.
The behaviors of the HeLa cells after induction of hSkn-1a were interpreted in this study as part of the differentiation, not as nonspecific toxicity of the protein, because lacZ alone did not cause such effects and because those behaviors were observed in the context of the partial differentiation as indicated by some upregulated genes in both the induced HeLa/hSkn-1a cells and the differentiating keratinocytes. We reported recently that transcriptions of hSkn-1a, K10, ARHH (a gene encoding a small GTP-binding protein of ras family) and Cx43 (a gene encoding a component of conexin) genes are induced in both the doxycyclineinduced HeLa/hSkn-1a and the primary human keratinocytes that have started differentiation (Enomoto et al., 2003) . This indicates that biochemical pathways for differentiation are working, at least partly, in the HeLa cells expressing hSkn-1a. On the basis of these observations, we interpreted that the morphological and biochemical changes observed in this study (Figures 3  and 4 ) are likely to result from the partial differentiation of the HeLa cells, although to rule out completely a possibility of nonspecific toxicity would require a hypothetical mutant hSkn-la that cannot upregulate the K10 gene.
It is interesting that the emergence of flat cells and induction of apoptosis appear to have occurred only in a small number of HeLa/hSkn-1a cells out of many expressing hSkn-1a within a week after the induction (Figures 1c and d) . The molecular mechanism controlling such an occasional phenotypic change is not clear at present. Part of the phenomenon resembles the unequal division of a stem cell, which produces one daughter stem cell and one differentiating cell in the first step of a differentiation. The level of hSkn-1a may be one of the possible factors involved in the regulation of the unique dividing. Figure 7 G418-resistant colonies formed by the cells after transfection with pCMV-hSkn-1a/IRESneo or pCMV-DsRed/ IRESneo. Cells transfected with the pCMV-hSkn-1a/IRESneo or pCMV-DsRed/IRESneo (plasmids expressing hSkn-1a or DsRed1 along with neomycin resistance gene, respectively) were replated at an appropriate concentration in a 100 mm dish and cultured in the presence of G418. After 2-3 weeks, selected colonies were fixed and stained
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When a HeLa/hSkn-1a culture was maintained in the presence of doxycycline, the level of hSkn-1a was lowered gradually and came down to a very low level especially after a week (Figures 1c and d) . It is not likely that hSkn-1a directly inactivates the CMV promoter, from which the hSkn-1a gene is transcribed in HeLa/ hSkn-1a. As is generally observed with the expression of a foreign gene integrated in cellular DNA, the cells inefficiently producing the foreign protein may be selected and come to constitute a major population after repeated cell divisions. If hSkn-1a, which is repressive on the cell growth, were cytotoxic to HeLa cells, those insensitive to or producing less hSkn-1a would have an advantage in surviving in the presence of doxycycline. We attempted to prepare a HeLa S3 clone stably expressing hSkn-1a, but could not (unpublished observation). The failure may be accounted for by the probable cytotoxicity of hSkn-1a for HeLa cells.
The experiments with transiently expressing hSkn-1a and the colony inhibition assay showed that hSkn-1a is suppressive on the growth (or triggers the resumption of partial differentiation) of the cervical cancer cell lines tested and an immortalized keratinocyte line, and also on the growth of the two liver carcinoma cell lines tested and monkey COS-1 cell line. This suggests that hSkn-1a is effective not only on those of keratinocyte origin but also on other types. Alexander is particularly interesting, in that, after the introduction of the hSkn-1a gene, it does not produce K10 mRNA but becomes susceptible to apoptosis and colony inhibition presumably caused by hSkn-1a. It is possible that the production of hSkn-1a is not directly linked to the terminal differentiation leading to apoptosis.
In view of the application to gene therapy for cancer, hSkn-1a appears to be moderate and not so dramatic in showing repressive effects on the cell growth. It is possible, however, that hSkn-1a, as a candidate for the therapeutic molecule in differentiation therapy, may be used in combination with other strategies, such as an antisense RNA strategy (Watanabe et al., 1993) . It is known that the growth of the cervical cancer cells harboring human papillomavirus DNA is repressed by an antisense RNA to the viral E6E7 genes. The combination of these strategies may be useful if an appropriate targeting vector is developed.
Materials and methods

Cells
Human cell lines, HeLa S3, SiHa, and CaSki (derived from cervical cancer), Alexander and HepG2 (from liver cancer), HEK293 (fibroblast transformed with adenovirus E1 gene), HaCaT (immortalized keratinocyte from skin), and a monkey epithelial cell line, COS-1, were cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen Corp., Carlsbad, CA) with fetal calf serum (FCS) (10%). A human cell line, C-33A (derived from cervical cancer), was cultured in minimum essential medium (MEM) (Invitrogen Corp.) with FCS (10%). HeLa/Tet-On cells (BD Biosciences Clontech, Palo Alto, CA, USA) were cultured in DMEM with FCS (10%) and G418 (200 mg/ml). The cell cultures were incubated at 371C in a humidified CO 2 incubator.
Construction of plasmids
The DNA fragment containing hSkn-1a coding region was excised from pGEM-T/hSkn-1a (Kukimoto and Kanda, 2001 ) by digestion at the multicloning site with EcoRI or with NotI. The EcoRI fragment was inserted into pIRESneo (BD Biosciences Clontech) and pTRE (BD Biosciences Clontech) at their EcoRI sites to generate pCMV-hSkn-1a/IRESneo and pTRE/hSkn-1a, respectively. The NotI fragment was inserted into pShuttle (BD Biosciences Clontech) at its NotI site to generate pShuttle/hSkn-1a. A NotI linker was inserted into pDsRed1-N1 (BD Biosciences Clontech) at the SmaI site, and then the DNA fragment containing DsRed1 coding region was excised by digestion with NotI and inserted into pIRESneo at the NotI site to generate pCMV-DsRed/IRESneo.
Transfection of DNA
Subconfluent culture of the cells in a 60 mm dish or 100 mm dish were transfected with 1 or 2 mg of plasmid DNA, respectively, using Effectene Transfection Reagent (QIAGEN GmbH, Hilden, Germany).
Preparation of a HeLa cell line that expresses hSkn-1a in the presence of doxycycline
The tetracycline-inducible expression system and the HeLa/ Tet-On cells, which is a HeLa clone expressing reverse tetracycline-controlled transactivator, were purchased from BD Biosciences Clontech. HeLa/Tet-On (1 Â 10 6 ) in a 100 mm culture plate were transfected with a mixture of ScaI-cleaved pTRE/hSkn-1a (2 mg) and HpaI-cleaved pTK-Hyg, a plasmid expressing hygromycin resistance gene (BD Biosciences Clontech) (0.1 mg). The cells were cultured in the medium containing hygromycin (200 mg/ml), and 96 drug-resistant clones were obtained. Induction of hSkn-1a with doxycycline (10 mg/ml) was examined by immunoblotting with anti-Skn-1a rabbit polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and a clone, designated as HeLa/hSkn1a, which showed the lowest level of hSkn-1a without doxycycline and the highest with doxycycline was selected.
Construction of an adenovirus vector capable of expressing hSkn-1a
The E1/E3-deleted adenovirus vectors expressing hSkn-1a (Ad/hSkn-1a) or lacZ (Ad/lacZ) were generated according to the instruction of Adeno-X Expression System (BD Biosciences Clontech). Expression cassettes were excised from pShuttle/hSkn-1a and pShuttle/lacZ (BD Biosciences Clontech) by I-CeuI and PI-SceI digestion and inserted into pAdeno-X (BD Biosciences Clontech). The recombinant adenovirus genome excised from the backbone vector by digestion with PacI was transfected to HEK293 using Effectene Transfection Reagent (QIAGEN GmbH). The recombinant virus propagated in HEK293 cells were obtained from the culture medium and cell lysate. The virus propagated in HEK293 inoculated with the first stock of the virus was purified by Adeno-X Virus Purification Kit (BD Biosciences Clontech) and used in the experiments. Virus infectivity was titerated by Adeno-X Rapid Titer Kit (BD Biosciences Clontech). hSkn-1a in cells infected with Ad/hSkn-1a was detected by immunohistochemistry using anti-Skn-1a antibody and LSAB2 Systems (DAKO Corp., Carpinteria, CA, USA). LacZ in cells infected with Ad/lacZ was detected by In Situ b-galactosidase Staining Kit (Stratagene Cloning Systems, La Jolla, CA, USA).
Immunofluorescence staining
Cells grown in a Lab-Tek chamber slide (Nalge Nunc Internatioal Corp., Rochester, NY, USA) were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 10 min at room temperature. After washing with PBS, the slide was incubated with anti-Skn-1a antibody diluted at 1 to 200 in PBS containing 3% bovine serum albumin (BSA) for 30 min at room temperature. The slide was washed with PBS and incubated with AlexaFluor488-conjugated anti-rabbit IgG antibody (Molecular Probes, Inc., Eugene, OR, USA) diluted at 1 to 400 in 3% BSA/PBS for 30 min at room temperature. After washing with PBS, the slide was covered with a coverslip using Slow-Fade Antifade kit (Molecular Probes, Inc.) and examined under a UV microscope (Olympus Co Ltd., Tokyo, Japan).
Labeling with BrdU
For BrdU labeling study, HeLa/hSkn-1a grown in a Lab-Tek chamber slide were labeled in a medium containing 10 mM BrdU for 15 min at 371C. The incorporated BrdU were visualized by immunohistochemistry using 5 0 -Bromo-2 0 -deoxy-uridine Labeling and Detection Kit II (Roche Diagnostics GmbH, Mannheim, Germany).
Detection of apoptosis
